Are CSDX insiders buying or selling?

In the last 90 days, CS Diagnostics (CSDX) had 0 insider transactions. Track every executive trade, dollar amount, and date.

Which hedge funds own CSDX?

See every hedge fund and asset manager holding CS Diagnostics (CSDX).

How much of CSDX trades in dark pools?

Track CS Diagnostics (CSDX) dark pool activity and off-exchange block trades.

CS Diagnostics (CSDX) Smart Money — Insiders, Congress, Hedge Funds

$0.01

+0.00 (+0.00%)

OTC · Healthcare · Medical - Devices · Tech Score Sell · Power 39 · $2.1M mcap · 137M float · 0.075% daily turnover · Short 56% of daily vol

Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Dividends Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest Supply Chain

Smart Money Score

No convergence signal

Key Statistics

Market Cap$2.1M

52W Range0.0005-0.4

Volume100

Avg Volume102,897

Beta-9.74

Dividend—

Analyst Ratings

No analyst coverage

Company Info

CEOThomas Fahrhoefer

Employees1

SectorHealthcare

IndustryMedical - Devices

IPO Date2005-02-17

Websitecsdcorp.us

1603 Capitol Avenue
Cheyenne, WY 82001
US

49 21311510871

About CS Diagnostics Corp.

Headquartered in Neuss, Germany, CS Diagnostics Corp. was established in 1996. The company is dedicated to the development, production, and worldwide distribution of a range of health and medical-grade products, catering to both domestic German and international markets. Among its key offerings are MEDUSA, an exclusive surface disinfectant, and CS-Protect Hydrogel, a specialized tissue-spacing gel for radiation therapy applications. The firm rebranded as CS Diagnostics Corp. in August 2023, having previously operated under the name FlashZero Corp.

Latest News